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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not
individualized diet restriction based on IgG against foods is effective as migraine prophylaxis in
adults who suffer from migraines.
Study Design: Systematic review of three English language primary studies, published between
2009-2011.
Data Sources: Two randomized controlled trials and one case report published after 1996
comparing migraine frequency before and after diet elimination based on IgG against foods were
obtained using PubMed and Cochrane databases.
Outcomes Measured: Migraine frequency, recorded by patients in a headache diary throughout
the duration of the diet, was the primary outcome measured. Subjects reported baseline migraine
frequency and characteristics through a baseline diet phase6 or through a focused questionnaire,8
and results were compared after the completion of the diet phase.
Results: None of the studies reported any intervention-related adverse events or side effects.
Alpay and colleagues showed a statistically significant reduction in the number of headache days
and migraine attacks,6 with a NNT of 34. Mitchell and colleagues showed a statistically
significant reduction in migraine frequency at week 4 of the elimination diet, but after a full 12
weeks, the difference was not statistically significant.8 In a case report by Nelson-Dooley,9 the
patient showed a subjective reduction of migraine frequency compared to baseline.
Conclusions: Some reduction of migraine frequency was demonstrated by all three studies,
however the evidence is inconclusive. This can be attributed to a statistically significant
reduction in migraine frequency but a high NNT in the study by Alpay and colleagues,
conflicting evidence (migraine frequency at 4 weeks vs. 12 weeks) in the study by Mitchell and
colleagues, and the multiple simultaneous treatment interventions and subjective results in the
case report by Nelson-Dooley. Larger studies with a longer intervention period (>4 weeks),
emphasizing more controlled diets/meal plans and elimination of confounding factors may
clarify these inconsistent study results. Thus, future study is warranted to evaluate prophylactic
diet elimination based on IgG against foods for migraine frequency reduction before routine use
is recommended.
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Allergy & Migraine Prophylaxis
Cicioni 1

INTRODUCTION
Migraine is a highly prevalent episodic headache disorder, which presents as a unilateral,
throbbing head pain beginning in childhood, or more commonly in adolescence or early
adulthood1. It affects approximately 15% of females and 6% of males every year and accounts
for the second most common cause of headache.2 Not only does it causes a disabling effect on
quality of life for migraine sufferers, but requires approximately 4-6 days of bed rest per year.8
In the United States, migraine costs estimate as much as $17 billion annually, which is the sum
of outpatient visits, medications, laboratory and diagnostic services, management of side effects,
and lost productivity in the workplace.3 The total number of healthcare visits yearly worldwide
has not been quantified; however, patients average 2.78 doctor/clinic visits, 0.53 emergency
department visits, and 0.06 hospital admissions annually.4
Symptoms of migraine include an episodic headache that is unilateral, throbbing, and
aggravated by movement which can last for hours to days. It can be associated with specific
features, such as phonophobia, photophobia, nausea, and vomiting. In 20-25% of patients, the
headache is preceded by an aura, which is a visual disturbance often characterized by flashing
lights or zigzag lines.2
Currently, there is no unifying theory regarding the pathogenesis of migraine, and the
etiology is not completely understood. It appears to be multifactorial in nature, and may be
related to emotional state, genetics, vascular factors, trigeminal activation, serotonin imbalance,
hormonal changes, and various triggers1 that may ultimately lead to an inflammatory response in
the meninges.5 Such triggers have yet to be definitively identified, but they may include excess
or withdrawal of caffeine, changes in barometric pressure, bright lights or loud sounds, hunger,
stress, physical exertion, lack of sleep, and specific dietary items.2 Specific foods that have been
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linked to migraines in some patients include peanuts, oranges, tomatoes, onions, fatty foods, and
foods high in tyramine, including but not limited to red wine, chocolate, cheese, and processed
meats. However, controlled trials have proved these associations with specific foods invalid.1
Because the pathophysiology is not completely understood, various treatments are
currently being used for migraine, including abortive and prophylactic treatments. Abortive
treatment is indicated at the onset of migraine symptoms, and the most effective current therapy
includes triptans/5-HT1 agonists (e.g. sumatriptan, zolmitriptan, naratriptan) and ergot alkaloids
(e.g. ergotamine, dihydroergotamine)1. Other symptomatic treatment includes opioid
analgesics, NSAIDs, aspirin, barbiturates, and antiemetics. Prophylactic measures include beta
blockers (eg. propranolol, timolol), antiepileptic medications (eg. divalproex, topiramate), and
botulinum toxin injections. Additional treatments include calcium channel blockers, tricyclic
antidepressants, and selective serotonin reuptake inhibitors (SSRIs).3 Further prophylaxis
includes behavior modification, including avoidance of triggers including foods and limiting
caffeine intake. Chiropractic manipulation, meditation, acupuncture, and biofeedback may also
be beneficial in effective migraine prophylaxis.1
Such prophylactic measures need to be tailored to each patient depending on the
individual identified triggers and exacerbating factors. The success rate of current prophylactic
methods is inadequate in many migraine sufferers, and thus studying the individual triggers is
appropriate to attempt to reduce attack frequency. Hidden food allergy has been linked to
migraine since the 1930s.6 Early studies showed food elimination to be successful in preventing
migraines, and more recent research suggests that food intolerance or hypersensitivity may
precipitate migraine attacks.7 Clinically, food hypersensitivity is often determined empirically,
by elimination and challenge diets of suspected foods. However, this process has many
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limitations for practitioners, as it is time consuming and challenging to test all existing food
combinations. A newer alternative is to test for food specific IgG antibodies to particular foods
through a blood test called Enzyme Linked Immuno-Sorbent Assay (ELISA). Positive IgG
antibodies to specific foods may indicate a patient’s hypersensitivity to those foods. All IgG
subclasses, with the exception of IgG4, begin an inflammatory reaction when the antigen is
introduced.6 Theoretically, food with hypersensitivities may act as a patient’s migraine triggers.
Therefore, the ELISA test has potential to serve as a basis for food elimination diets to prevent
chronic inflammation and onset of migraine.6,8,9

OBJECTIVE
The objective of this selective EBM review is to determine whether or not individualized
diet restriction based on IgG against foods is effective as migraine prophylaxis in adults who
suffer from migraines.

METHODS
The criteria used for the selection of the three studies included migraine sufferers without
aura over 18 years old. Intervention included individualized diet restriction based on IgG
antibodies, determined by ELISA. Variations existed between studies. Diet restriction based on
elevated IgG to foods was compared to a “sham” diet (random elimination diet) in one
randomized controlled trial or to a provocation diet (inclusion of foods with elevated IgG) in
another randomized controlled trial, and to previous symptoms in one case report. Outcomes
evaluated in these studies included migraine attack count and number of headache days.
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Data was collected using PubMed, the Cochrane Database of Randomized Controlled
Trials, and the Cochrane Databases of Systematic Reviews from 2009-2012. Key words used
include “migraine prophylaxis,” “diet restriction,” “food elimination,” and “IgG.” All studies
were published in peer-reviewed journals in the English language and were selected on the basis
of importance of outcomes to the patient (Patient Oriented Evidence that Matters, POEMS). All
studies focused on prophylaxis of migraine attacks using diet elimination based on IgG to foods.
Inclusion criteria were participants over 18 years old experiencing migraine without aura;
additional criteria were defined by studies (see Table 1). Exclusion criteria included outcomes
that were not patient oriented and patients under 18 years old. Statistics used to evaluate patient
outcomes included: p-value, CI, and IRR. The demographics and characteristics of the studies
are shown in Table 1.
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Table 1. Demographics & Characteristics of Included Studies
Study
Type
#
Age
Inclusion
Exclusion
Pts
(yrs)
Criteria
Criteria
Alpay5
Double 30
35±10 >4 attacks and Suspected
medication
(2010)
blind
>4 headache
overuse;
RCT
days/month;
pure
age 18-55;
menstrual
treated with
migraine;
acute attack
medications or any other
associated
preventative
headache
medications
disorder
unchanged for
3 months; able
to understand/
cooperate with
study needs
and diet
Mitchell6 RCT
167 Sham >2 migraine
Any other
(2011)
diet:
like attacks or
significant
47.1
>4 headache
co±10.1 days in the
existing
previous 4
pathology;
True
week period;
no food
diet:
age 18-65; >1
sensitivity
48.3
food
on the
±11.0 intolerances
ELISA
identified from test
the ELISA test
(>10 AU/ml for
any one food)
Nelson- Case
1
40
40 y.o. female
N/A
7
Dooley Report
with mood
(2009)
swings,
migraines, and
weight gain &
PPMH of
depression.

W/D

Interventions

5

Individualized diet
excluding specific
foods with raised
IgG antibodies x 6
weeks

21

True diet (removal
of intolerant foods
from their diet) x 12
weeks

N/A

Rotation diet plan:
elimination of foods
with corresponding
elevated IgG levels,
rotated sparingly
into diet; fish oil 1
cap PO BID;
Women’s symmetry
multivitaminmineral 1 tab PO
daily; Probiotics 1
cap PO daily;
glutamine 1 tsp. PO
BID; free-form
amino acid blend
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OUTCOMES MEASURED
All outcomes measured were POEMs related to decreasing migraine frequency.
Outcomes regarded as favorable in the study by Alpay and colleagues included reduction in
attack count, number of headache days, number of attacks with acute medication, total
medication intake, median attack severity, and mean attack duration; unfavorable outcomes were
an increase in the previously mentioned values. All measures were recorded in individual
headache diaries which were analyzed at baseline and at the end of each of two six week diet
phases (randomized elimination and provocation diets).6
Mitchell and colleagues regarded a decrease in number of headache days and a lower
score on the Migraine Disability Assessment Scale (MIDAS) and Headache Impact Test (HIT6 ) to be favorable outcomes. Increased values were considered unfavorable outcomes. Such
values were reported by patients in a baseline questionnaire and migraine symptoms and diet
adherence were recorded in a 12 week diary.8
In a case study, Nelson-Dooley regarded a patient-reported decrease in intensity and
frequency of migraines, as well as decreased medication use during attacks as favorable
outcomes.9

RESULTS
Three studies compared the use of elimination diets based on positive IgG antibodies
against foods to prevent migraines in patients over 18 years old with a history of migraine
without aura. One was a double-blind randomized controlled cross over trial,6 one was a single
blind randomized controlled trial,8 another was a case report.9 No intervention-related negative
side effects or adverse events were reported in any of the studies.
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Alpay and colleagues studied 30 patients diagnosed with migraine without aura who were
recruited from a headache outpatient clinic. Patients excluded from the study included those
who had suspected medication overuse, pure menstrual migraine, and any other headache
disorder to maximize the results by eliminating patients that had known migraine etiologies.
Each participant underwent a 6 week provocation diet followed by a 6 week elimination diet or
vice versa, separated by a 2 week diet-free interval.. Diets were based on IgG antibodies against
266 food antigens detected by ELISA, and patients had an average of 24±11 food
hypersensitivities. Patients recorded symptoms in individual headache diaries and the number of
headache days, and migraine attack count was analyzed. A reduction in the number of headache
days (10.5±4.4 at baseline to 7.5±3.7 on elimination diet; p<0.001, 95% CI) and number of
migraine attacks (9.0± 4.4 at baseline to 6.2±3.8 on elimination diet; p<0.001, 95% CI) was
observed.6 However, the number needed to treat (NNT) is 34. Thus, the difficulty in completely
removing approximately 24 foods (average number of food hypersensitivities) in addition to the
cost of the ELISA and clinician visits needs to be considered especially because only one of
every 34 patients will experience significant reduction (> 50%) of migraine attack count.
Table 2. Analysis of Outcomes and Numbers Needed to Treat in Patients Undergoing IgG
Based Diet Restriction for Migraine Prophylaxis by Alpay et al.6
Study
Number
CER (%)
EER
RRI
ARR (%)
NNT
Author
of patients
Alpay

30

20

23

1

3

34

Mitchell et al studied 167 patients recruited through advertisements and a press release
with self-reported headaches that were ‘migraine like’ for at least 12 months according to their
baseline questionnaire. Candidates with no identified food intolerance identified on the ELISA
test were excluded in the study, as well as those who have significant co-existing pathology.
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Participants underwent either a true diet (elimination of foods with elevated IgG on ELISA) or a
sham diet in the control group for 12 weeks. Patients were asked to record frequency, symptoms,
medication use, and clinician visits, and MIDAS and HIT-6™ at baseline, as well as all migraine
qualities and diet compliance in a daily diary throughout the 12 week diet period. Patients were
followed up at 4 and 12 weeks, and diaries were analyzed. At 4 weeks, the number of migraine
like headaches was reduced from baseline (IRR 95% CI 1.01 to 1.50, p=0.04); however after a
full 12 weeks, the difference was not statistically significant (IRR 1.15 95% CI 0.94 to 1.41,
p=0.18).8 Because the outcomes measured were not dichotomous, NNT could not be calculated.
Table 3. Analysis of Outcome of Number of Headache Days in Patients Undergoing IgG
Based Diet Restriction for Migraine Prophylaxis by Mitchell et al. 8
Time point
IRR
95% CI
p
12 weeks

1.15

0.94-1.41

0.18

4 weeks

1.23

1.01-1.50

0.04

In a case report by Nelson-Dooley, a 40-year-old female patient diagnosed with migraine
and mood disorder had migraines 4-6 times per week. Plasma amino acids, urinary
neurotransmitter catabolites, and serum food antibodies were obtained. The patient’s enzyme
immunoassay showed severe antibody reaction (+5) to casein, milk, and egg white, moderate
antibody reactions (+3/+4) to 22 foods and mild antibody reactions (+1/+2) to 5 foods. The
patient eliminated all foods with IgG levels of +4 and +5 for one month, and then slowly rotated
them into her diet. Foods with +1 to +3 antibodies were rotated <2 times per week. This was
continued for 90 days. The patient was also simultaneously prescribed various other
interventions (see Table 1). Results were subjective, and reportedly the frequency of migraine
attacks was “greatly reduced,” and occurred only with menses versus “all the time” at baseline.
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Medication use was decreased from weekly at baseline to monthly at the end of the diet. The
patient did report difficulty complying with the diet, especially avoiding eggs and dairy.9

DISCUSSION
Specific food triggers are known to provoke migraine attacks in some individual patients,
and because the triggering foods vary from patient to patient,2 it may be related to hidden food
allergy.5,6,8 Therefore, individual diet plans to prevent migraine headaches are warranted and
may be key to future therapy for this common debilitating syndrome.
However, limitations exist in obtaining evidence for expansion of the theory describing
allergy mediated inflammation triggering migraine attacks. The following are limitations shared
amongst all three studies. Symptoms and severity are highly dependent on the individual patient
and are entirely subjective. Additionally, there may be many migraine triggers for each
individual patient, which may include and are not limited to bright lights, stress, lack of sleep,
missed meals, and menses.2 It is unrealistic and nearly impossible to eliminate all of these
confounding factors in order to definitely pinpoint one element as the sole migraine trigger.
Regarding study designs, adhering to an elimination diet can be challenging, especially when
patients have multiple food intolerances. Being conscious of ingredients, especially when dining
out or eating processed foods, makes the task more daunting to strictly adhere to such a diet.
There were also specific limitations in the study design by Alpay and colleagues.
Because the patients were modifying their diets at home based on the assigned diets and food
was not supplied to the patients, compliance to the intervention was unknown and unmeasured.
In the same study, the sample size was small (n=30), making it difficult to generalize the results
to an entire population of patients diagnosed with migraine. Five patients withdrew from the
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study for reasons such as “moving to another city,” “unwillingness to maintain diet,” or
“skipping the visit,” and worst case analysis was not completed to account for the lost subjects.
Additionally, because the author did not include a table of patient demographics, the results
cannot be generalized to similar patients because the type of patients is unknown.
One of the weaknesses of the study by Mitchell and colleagues is that the participants had
self-reported migraines and were not required to be clinically diagnosed with migraine by a
medical provider to be included in the study. It is possible that some of the participants were
suffering from other forms of headache, so the dietary manipulation would be ineffective or
simply inappropriate. The daily diary was a limitation as well, as only 52% of patients on the
true diet returned their completed diary so adherence is unknown in the other 48%. Additionally,
because all patients were volunteers recruited through advertising, they may be more willing to
comply with challenging diet modifications than the average patient.
The major drawback in the case study by Nelson-Dooley, was the simultaneous
introduction of various prescriptions and interventions with the change in diet, all of which were
initiated at the same time. It makes it difficult to accurately correlate the elimination diet with
the patient’s reported decrease in migraine symptoms and severity. Additionally, the author did
not report any measurable outcomes (eg. numerical pain scale rating); the outcomes were purely
subjective and patient reported. Again, because the sample size only included one patient who
also had another co-morbid diagnosis, these results cannot be generalized to an entire population.
The ELISA food panel itself is widely available and accessible at a variety of lab
companies in the U.S., but the number and types of foods tested varies in each laboratory. The
test is more sensitive than skin prick testing in allergy testing , is a safer choice in patients at risk
for anaphylaxis or provocation of symptoms, and the single venipuncture required is easier to
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tolerate. However, it is more expensive than skin prick methods. Because ELISA for food
allergy is not typically indicated for patients with head pain, insurance coverage is dependent on
the insurer and individual plan. Current indications for the ELISA food panel are used
diagnostically for allergy mediated respiratory and gastrointestinal symptoms and diseases.
There are no current contraindications or risks of the test itself.10

CONCLUSIONS
Some reduction of migraine frequency was demonstrated by all three studies, however
the evidence is inconclusive. Because the sample size in the study by Alpay and colleagues was
small and the NNT was high, results are not generalizable and may not be worthwhile for the
average adult with migraines. The results shown by Mitchell and colleagues are conflicting, as a
statistically significant reduction in migraine frequency was demonstrated at 4 weeks, but not at
the completion of the study (12 weeks). In the case study by Nelson-Dooley9, multiple
simultaneous treatment interventions and subjective reduction in migraine frequency does not
conclusively demonstrate that symptom reduction correlates with elimination diet alone.
Future study to evaluate prophylactic diet elimination based on IgG against foods for
migraine frequency reduction is warranted. Larger studies with a longer intervention period (>4
weeks), with more controlled meals involving supplied meals for participants is necessary to
ensure that the diet is more strictly enforced and monitored. Removal of confounding factors
during the diet phase may implement the direct relationship between migraine and food allergy.
Although the reviewed studies do show some promise, additional research is necessary before
the use of an elimination diet for reduction of migraine frequency is recommended routinely.
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